Skip to main content
SpringerLink
Log in

Corticosteroids

  • Chapter
Intraocular Inflammation

Abstract

Gordon and Mc Lean [1] in 1950 introduced the use of corticosteroid and ACTH for ophthalmic use. The first rational use of prednisone and prednisolone for ocular inflammatory diseases was described by Gordon in 1956 where topical steroid was found to be efficacious in anterior segment disease and systemic steroid was preferred for posterior segment disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gordon DM, McLean JM (1950) Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions. JAMA 142:1271–1276

    Article  Google Scholar 

  2. Fauci AS (1978) Clinical aspects of immunosuppression:use of cytotoxic agents and corticosteroids. In: Immunology. WB Saunders, Philadelphia

    Google Scholar 

  3. Nussenblatt RB, Whitcup SM, Palestine AG (1996) Uveitis: fundamentals and clinical practice. Mosby, St. Louis

    Google Scholar 

  4. Leopold IH, Maylath R (1952) Intraocular penetration of cortisone and its effectiveness against experimental corneal burns. Am J Ophthalmol 42:1125–1134

    Article  Google Scholar 

  5. Leopold IH, Kroman HS (1960) Methyl- and fluoro-substituted prednisolones in the blood and aqueous humor of the rabbit. Concentrations. Arch Ophthalmol 63:943–947

    Article  CAS  PubMed  Google Scholar 

  6. Weijtens O, Feron EJ, Schoemaker RC et al (1999) High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection. Am J Ophthalmol 128:192–197

    Article  CAS  PubMed  Google Scholar 

  7. McGhee CN (1992) Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol 76:681–684

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Schoenwald RD, Stewart P (1980) Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci 69:391–394

    Article  CAS  PubMed  Google Scholar 

  9. Awan MA, Agarwal PK, Watson DG et al (2009) Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol 93:708–713

    Article  CAS  PubMed  Google Scholar 

  10. Weijtens O, Schoemaker RC, Romijn FP et al (2002) Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 109:1887–1891

    Article  PubMed  Google Scholar 

  11. Koff R, Rome S, Commons RR et al (1950) Subconjunctival injection of cortisone in iritis. J Am Med Assoc 144:1259–1260

    Article  CAS  PubMed  Google Scholar 

  12. Athanasiadis Y, Tsatsos M, Sharma A et al (2013) Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease. J Ocul Pharmacol Ther 29:516–522

    Article  CAS  PubMed  Google Scholar 

  13. Nozik RA (1976) Periocular injection of steroids. Trans Am Acad Ophth Otol 76:695–704

    Google Scholar 

  14. Beer PM, Bakri SJ, Singh RJ et al (2003) Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110:681–686

    Article  PubMed  Google Scholar 

  15. McCuen BW 2nd, Bessler M, Tano Y et al (1981) The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 91:785–788

    Article  CAS  PubMed  Google Scholar 

  16. Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190–195

    Article  CAS  PubMed  Google Scholar 

  17. Stepien KE, Eaton AM, Jaffe GJ et al (2009) Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006. Retina 29:207–213

    Article  PubMed  Google Scholar 

  18. Driot JY, Novack GD, Rittenhouse KD et al (2004) Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period. J Ocul Pharmacol Ther 20:269–275

    Article  CAS  PubMed  Google Scholar 

  19. Thorne JE, Woreta FA, Dunn JP, Jabs DA (2010) Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology 117(7):1436–1441

    Article  PubMed Central  PubMed  Google Scholar 

  20. Kumar S, Shah S, Deutsch ER et al (2013) Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes. Invest Ophthalmol Vis Sci 54(2):1280–1287

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Slabaugh MA, Herlihy E, Ongchin S, van Gelder RN (2012) Efficacy and potential complications of difluprednate use for pediatric uveitis. Am J Ophthalmol 153(5):932–938

    Article  CAS  PubMed  Google Scholar 

  22. Jaffe GJ, Martin D, Callanan D et al (2006) Fluocinolone Acetonide Uveitis Study Group. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study. Ophthalmology 113:1020–1027

    Article  PubMed  Google Scholar 

  23. Arcinue CA, Cerón OM, Foster CS (2013) A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. J Ocul Pharmacol Ther 29:501–507

    Article  CAS  PubMed  Google Scholar 

  24. Say EA, Shields CL, Bianciotto C, Shields JA (2011) Perilymphatic subcutaneous fat atrophy and cutaneous depigmentation after periocular triamcinolone acetonide injection in a child. J AAPOS 15(1):107–108

    Article  PubMed  Google Scholar 

  25. Jonas JB, Kamppeter BA (2005) Intravitreal triamcinolone acetonide and central serous chorioretinopathy. Br J Ophthalmol 89(3):386–387

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Malclès A, Janin-Manificat H, Yhuel Y et al (2013) Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases. J Fr Ophtalmol 36:362–367

    Article  PubMed  Google Scholar 

  27. Bansal R, Bansal P, Kulkarni P et al (2012) Wandering Ozurdex(®) implant. Ophthalmic Inflamm Infect 2:1–5

    Article  Google Scholar 

  28. Ufret-Vincenty RL, Singh RP, Lowder CY, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. Am J Ophthalmol 143:334–335

    Article  PubMed  Google Scholar 

  29. Ramaiya KJ, Rao PK (2011) Herpetic necrotizing retinitis following flucinolone acetonide intravitreal implant. Ocul Immunol Inflamm 19:72–74

    Article  PubMed  Google Scholar 

  30. Sims JL, Chee SP (2010) Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant. Eye 24:197–198

    Article  CAS  PubMed  Google Scholar 

  31. Park UC, Kim SJ, Yu HG (2011) Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis. Ocul Immunol Inflamm 19:282–283

    Article  PubMed  Google Scholar 

  32. Rofagha S, Prechanond T, Stewart JM (2013) Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert). Ocul Immunol Inflamm 21:62–63

    Article  Google Scholar 

  33. Akduman L, Cetin EN, Levy J et al (2013) Spontaneous dissociation and dislocation of Retisert pellet. Ocul Immunol Inflamm 21:87–89

    Article  PubMed  Google Scholar 

  34. Otsuka H, Kawano H, Sonoda S et al (2013) Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Invest Ophthalmol Vis Sci 54(3):1758–1766

    Article  PubMed  Google Scholar 

  35. Foster CS, Davanzo R, Flynn TE et al (2010) Durezol (Difluprednate Ophthalmic Emulsion 0.05 %) compared with Pred Forte 1 % ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther 26:475–483

    Article  CAS  PubMed  Google Scholar 

  36. Helm CJ, Holland GN (1995) The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol 120:55–64

    Article  CAS  PubMed  Google Scholar 

  37. Leder HA, Jabs DA, Galor A et al (2011) Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol 152:441–448

    Article  CAS  PubMed  Google Scholar 

  38. Salek SS, Leder HA, Butler NJ et al (2013) Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis. Ocul Immunol Inflamm 21(4):257–263

    Article  CAS  PubMed  Google Scholar 

  39. Ferrante P, Ramsey A, Bunce C et al (2004) Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis. Clin Experiment Ophthalmol 32:563–568

    Article  PubMed  Google Scholar 

  40. Habot-Wilner Z, Sallam A, Pacheco PA et al (2011) Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema. Eur J Ophthalmol 21(Suppl 6):S56–S61

    Article  PubMed  Google Scholar 

  41. Sallam A, Comer RM, Chang JH et al (2008) Short-term safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema in children. Arch Ophthalmol 126:200–205

    Article  PubMed  Google Scholar 

  42. Roesel M, Tappeiner C, Heinz C et al (2009) Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis. Am J Ophthalmol 147:406–412

    Article  CAS  PubMed  Google Scholar 

  43. Okhravi N, Morris A, Kok HS et al (2007) Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study. J Cataract Refract Surg 33:1278–1283

    Article  PubMed  Google Scholar 

  44. Williams GA, Haller JA, Kuppermann BD et al (2009) Dexamethasone DDS Phase II Study Group. Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 147:1048–1054

    Article  CAS  PubMed  Google Scholar 

  45. Lowder C, Belfort R Jr, Lightman S et al (2011) Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 129:545–553

    Article  PubMed  Google Scholar 

  46. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Holbrook JT et al (2011) Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology 118(10):1916–1926

    Article  Google Scholar 

  47. Pavesio C, Zierhut M, Bairi K, Comstock TL, Usner DW, Fluocinolone Acetonide Study Group (2010) Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology 117:567–575

    Article  PubMed  Google Scholar 

  48. Jabs DA, Rosenbaum JT, Foster CS et al (2000) Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 130:492–513

    Article  CAS  PubMed  Google Scholar 

  49. Antcliff RJ, Spalton DJ, Stanford MR et al (2001) Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 108:765–772

    Article  CAS  PubMed  Google Scholar 

  50. Das-Bhaumik RG, Jones NP (2006) Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis. Eye 20:934–937

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Proctor Foundation, UCSF, San Francisco, CA, USA

    Mamta Agarwal DNB

  2. Uveitis and Cornea Services, Medical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, 600006, India

    Mamta Agarwal DNB

  3. Centre of Ophthalmology, University of Tuebingen, Schleichstr. 12, Tuebingen, 72076, Germany

    Manfred Zierhut MD, PhD

Authors
  1. Mamta Agarwal DNB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manfred Zierhut MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mamta Agarwal DNB .

Editor information

Editors and Affiliations

  1. Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany

    Manfred Zierhut

  2. Biomedical Research Centre, Institute of Ophthalmology, Moorfields Eyes Hospital, Department of Medical Retina, UCL, London, United Kingdom

    Carlos Pavesio

  3. School of Medicine, Department of Ophthalmology, Hokkaido University Graduate, Sapporo, Hokkaido, Japan

    Shigeaki Ohno

  4. University of Belo Horizonte, Belo Horizonte, Brazil

    Fernando Orefice

  5. USC Eye Institute, University of Southern California, Los Angeles, California, USA

    Narsing A. Rao

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Agarwal, M., Zierhut, M. (2016). Corticosteroids. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75387-2_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75385-8

  • Online ISBN: 978-3-540-75387-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation